Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

97.14
Delayed Data
As of Apr 29
 -2.80 / -2.80%
Today’s Change
59.04
Today|||52-Week Range
110.68
+7.60%
Year-to-Date

Today’s Trading

Previous close99.94
Today’s open99.38
Day’s range95.93 - 100.00
Volume922,343
Average volume (3 months)663,960
Market cap$4.2B
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+1,372.22%
Earnings growth (this year)-69.94%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+25.41%
P/E ratio34.5
Price/Sales13.32
Price/Book14.17

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-1.07-1.48%
DXCMDexCom Inc-1.58-2.40%
NUVANuVasive Inc-0.16-0.30%
IARTIntegra LifeSciences...+0.70+1.00%
Data as of 4:02pm ET, 04/29/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$230.3M
Annual profit (last year)$113.7M
Net profit margin49.36%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Partner Offers

Search for Jobs